Replies to post #5501 on Safeplus International Holdings Ltd. (ACAI)

[sunspotter]

"i could see where someone would be upset if they thought BIPH actually brought most their techonolgy's to the public forum, but they don't, they sell them. thats what this company does."

I don't wish to be pedantic, but actually that's not what this company does, or rather did.

It actually bought the Myotech CSS device, for a sum that we can all agree was well over $10 million, and that the SEC filings and I would peg at $17 million.

(The inconvenient truth is that they bought it from a bunch of insiders, some of them associated with Biophan itself, some with TI and others who are part of the same clique, for example the Anstadts.)

Then they sold it, when it was clear that even the normally compliant shareholders weren't going to give them any more shares to give to toxic financiers, presumably because they figure that Weiner has a big enough yacht already, and that Mr. Lanzafame maybe didn't deserve annual remuneration of $629,000 as declared in BIPH's filings.

But they didn't sell it for $17 million, nor $10 million or even $1 million.

Instead they offloaded it at $250,000 and a nebulous part -20%- of an even more nebulous income stream to a shell company established by Biophan's current CEO, while at the same time removing even the small vestige of transparency that having to file with SEC required.

"20% of what is considered a break through technology is not horrible"

Sorry, but breakthrough technologies do not get sold for $250,000 and a mess of pottage, any more than they languish for several years without any kind of study or development on a real company's shelves. Besides which they had a 100% before they sold it to a brand new company with no other products and no track record of anything except Mr. Lanzafame's abject failure with Biophan.

Companies with breakthrough products attract real partners with real money, and have studies conducted on them. And the companies developing them shout about their progress from the rooftops to potential partners, set milestones and meet them.

Companies with breakthrough products don't focus on gulling potential investors through penny stock scam promoters like Agora Taipan and dishonest message board posters.